Establishment of new drug R & D cooperation agreement between Sihuan pharmaceutical and to BBB
Coating knowledge: coating R & D Engineer became the focus in July
Opening ceremony of Nippon Asia Pacific R & D Center Project
R & D daily essence pharmaceutical terminates two products R & D to cure diabetes or hope
R & D strategy and early R & D pipeline of Genentech
Xiamen issues measures to support the R & D and production of new coronavirus biomedicine
In the future, innovation in the pharmaceutical field will be the king, and the R & D investment of domestic pharmaceutical enterprises will grow steadily
AI pharmaceutical trend is obvious! What are the possibilities besides improving R & D Efficiency
R & D Daily: moxifloxacin hydrochloride injection approved for marketing
In the first three quarters of 2019, the R & D expenditure of these three pharmaceutical companies ranked first
2020 R & D pipeline report: which areas deserve attention
In 2020, these R & D areas deserve the attention of pharmaceutical companies
The R & D power of domestic drugs is increasing
Weisi medical transferred to scientific and technological innovation board, and there are hidden dangers in the proportion of R & D and sales
Readjustment of R & D pattern of pharmaceutical enterprises and operation focus of foreign enterprises
Another multinational pharmaceutical company, China's early R & D center closed
Dealway (China) Shanghai R & D center officially opened
International | aiside won the "Oscar" award of American science and technology circle - 100 innovation award of R & D
Dialogue with President of Takeda global R & D: is Takeda a M & A or R & D enterprise
Yunnan Baiyao released the third quarter report, with increased R & D investment and emphasis on strengthening the layout of biological drugs